AVR Anteris Technologies

Anteris Technologies to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

Anteris Technologies to Present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference

BRISBANE, Australia and EAGAN, Minn., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Anteris Technologies Ltd (ASX:AVR) (Anteris or the Company), a structural heart company advancing its novel DurAVR™ valve for aortic repair and replacement, today announced that Wayne Paterson, Chief Executive Officer, will present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Friday, February 19, 2021 at 10:30AM ET.

About Anteris Technologies Ltd (ASX:AVR)

Anteris Technologies Ltd is a structural heart company delivering clinically superior and durable solutions through better science and better design. Its focus is on developing next generation technologies that help healthcare professionals create life-changing outcomes for patients.

The Anteris DurAVR™ aortic replacement valve addresses the acute need in terms of superior hemodynamic profile as well as chronic needs in its ability to sustain that profile longer over the lifetime of the patient.

The proven benefits of its ADAPT® tissue technology, paired with DurAVR™’s unique 3D single-piece aortic valve design, has the potential to deliver a functional cure to aortic stenosis patients and provide a much-needed solution to the challenges facing heart surgeons today.

For more information:

Jason Wong

Blueprint Life Science Group

E:

P: (415) 375-3340 Ext. 4



Twitter: @AnterisTech

Facebook: /AnterisTech



EN
16/02/2021

Underlying

AVRAnteris Technologies

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Anteris Technologies

 PRESS RELEASE
Free
AVR Anteris Technol...

Anteris Technologies Global Corp. Announces Postponement of Special Me...

Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders MINNEAPOLIS and BRISBANE, Australia, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: , ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced that its Special Meeting of Stockholders (the “Special Meeting”), which was originally scheduled to be held on Thursday, September 11, 2025, at 5:00 p.m. Central time (being 8:00 a...

September 11, 2025 1 EN
 PRESS RELEASE
Free
AVR Anteris Technol...

Anteris Technologies Global Corp. Announces Postponement of Special Me...

Anteris Technologies Global Corp. Announces Postponement of Special Meeting of Stockholders MINNEAPOLIS and BRISBANE, Australia, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: , ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced that its Special Meeting of Stockholders (the “Special Meeting”), which was originally scheduled to be held on Thursday, September 4, 2025, at 5:00 p.m. Central time (being 8:00 a....

September 4, 2025 1 EN
 PRESS RELEASE
Free
AVR Anteris Technol...

Anteris Announces Results for the Second Quarter of 2025

Anteris Announces Results for the Second Quarter of 2025 MINNEAPOLIS and BRISBANE, Australia, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercialising cutting-edge medical devices to restore healthy heart function, today reported financial results for the quarter ended June 30, 2025, and provided a corporate update. Second Quarter 2025 Highlights 130 patients implanted with the DurAVR® THV since the start of clinical development; 49 pa...

August 11, 2025 1 EN
 PRESS RELEASE
Free
AVR Anteris Technol...

Anteris Appoints David Roberts and Gregory Moss to its Board of Direct...

Anteris Appoints David Roberts and Gregory Moss to its Board of Directors New Directors Bring Extensive NASDAQ Expertise Across Legal, Operational and Corporate Leadership Capacities MINNEAPOLIS and BRISBANE, Australia, June 09, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today announced the appointments of Mr. David Roberts and Mr. Gregory Moss to its Board of Directors. ...

June 10, 2025 1 EN
 PRESS RELEASE
Free
AVR Anteris Technol...

Anteris Announces Results for the First Quarter of 2025

Anteris Announces Results for the First Quarter of 2025 MINNEAPOLIS and BRISBANE, Australia, May 13, 2025 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. (Anteris or the Company) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today reported financial results for the quarter ended March 31, 2025, and provided a corporate update. First Quarter 2025 Highlights Investigational Device Exemption (“IDE”) for the DurAVR® THV’s global, pivotal clinical trial (t...

May 13, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch